Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2018

  • ID: 4516600
  • Report
  • Region: Europe
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The researcher announced the results of its Multiple Sclerosis patients study in a new research ‘Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2018’. The research provides insights into Multiple Sclerosis epidemiology, Multiple Sclerosis diagnosed patients, and Multiple Sclerosis treatment rate for EU5 countries. The research measures key indicators including prevalence of Multiple Sclerosis derived from epidemiological analysis, patients diagnosed with Multiple Sclerosis, and patients treated with a drug therapy.

The research study helps executives estimate Multiple Sclerosis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Multiple Sclerosis prevalence, Multiple Sclerosis diagnosis rate, and Multiple Sclerosis treatment rate for the period 2017 - 2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Features of the Report:
  • Multiple Sclerosis Patient Flow
  • Multiple Sclerosis Prevalence
  • Multiple Sclerosis Diagnosed Patients
  • Multiple Sclerosis Treated Patients
Note: Product cover images may vary from those shown
2 of 3
1. Multiple Sclerosis: Disease Definition
2. Multiple Sclerosis Patient Flow in Europe
2A. Multiple Sclerosis Prevalence in Europe
2B. Multiple Sclerosis Diagnosed Patients in Europe
2C. Multiple Sclerosis Treated Patients in Europe
3. Multiple Sclerosis Patient Flow in Germany
3A. Multiple Sclerosis Prevalence in Germany
3B. Multiple Sclerosis Diagnosed Patients in Germany
3C. Multiple Sclerosis Treated Patients in Germany
4. Multiple Sclerosis Patient Flow in France
4A. Multiple Sclerosis Prevalence in France
4B. Multiple Sclerosis Diagnosed Patients in France
4C. Multiple Sclerosis Treated Patients in France
5. Multiple Sclerosis Patient Flow in Spain
5A. Multiple Sclerosis Prevalence in Spain
5B. Multiple Sclerosis Diagnosed Patients in Spain
5C. Multiple Sclerosis Treated Patients in Spain
6. Multiple Sclerosis Patient Flow in Italy
6A. Multiple Sclerosis Prevalence in Italy
6B. Multiple Sclerosis Diagnosed Patients in Italy
6C. Multiple Sclerosis Treated Patients in Italy
7. Multiple Sclerosis Patient Flow in UK
7A. Multiple Sclerosis Prevalence in UK
7B. Multiple Sclerosis Diagnosed Patients in UK
7C. Multiple Sclerosis Treated Patients in UK
8. Research Methodology

List of Tables
Table 1: Multiple Sclerosis Patient Flow in Europe, 2017
Table 2: Multiple Sclerosis Patient Flow Forecast in Europe, 2017 - 2026
Table 3: Multiple Sclerosis Patient Flow in Germany, 2017
Table 4: Multiple Sclerosis Patient Flow Forecast in Germany, 2017 - 2026
Table 5: Multiple Sclerosis Patient Flow in France, 2017
Table 6: Multiple Sclerosis Patient Flow Forecast in France, 2017 - 2026
Table 7: Multiple Sclerosis Patient Flow in Spain, 2017
Table 8: Multiple Sclerosis Patient Flow Forecast in Spain, 2017 - 2026
Table 9: Multiple Sclerosis Patient Flow in Italy, 2017
Table 10: Multiple Sclerosis Patient Flow Forecast in Italy, 2017 - 2026
Table 11: Multiple Sclerosis Patient Flow in UK, 2017
Table 12: Multiple Sclerosis Patient Flow Forecast in UK, 2017 - 2026

List of Figures
Figures 1: Multiple Sclerosis Patient Flow in Europe, 2017
Figure 2: Multiple Sclerosis Patient Flow Forecast in Europe, 2017 - 2026
Figure 3: Multiple Sclerosis Patient Flow in Germany, 2017
Figure 4: Multiple Sclerosis Patient Flow Forecast in Germany, 2017 - 2026
Figure 5: Multiple Sclerosis Patient Flow in France, 2017
Figure 6: Multiple Sclerosis Patient Flow Forecast in France, 2017 - 2026
Figure 7: Multiple Sclerosis Patient Flow in Spain, 2017
Figure 8: Multiple Sclerosis Patient Flow Forecast in Spain, 2017 - 2026
Figure 9: Multiple Sclerosis Patient Flow in Italy, 2017
Figure 10: Multiple Sclerosis Patient Flow Forecast in Italy, 2017 - 2026
Figure 11: Multiple Sclerosis Patient Flow in UK, 2017
Figure 12: Multiple Sclerosis Patient Flow Forecast in UK, 2017 - 2026
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll